| hospital beds | 400.0 beds |
|---|
BSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹860.00
- Market cap
- ₹83,705 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 57.5×Sector 52.8×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY
Max Healthcare Institute Employee Stock Options
Max Healthcare's NRC approved 95,000 ESOPs at ₹800 exercise price under its 2022 scheme. Vesting spans 1-5 years with a 3-year post-vesting exercise window.
Other production started announcements
All →Gala Precision Engineering Production Started
Gala Precision Engineering commissioned a 1.20 MW open access solar plant at Nanded on October 30, 2026. The plant will supply captive power to its manufacturing facility.
- solar power capacity
- 1.2 MW
Waaree Energies Production Started
Waaree Solar Americas commenced commercial production of 1.6 GW solar modules at Brookshire, Texas. Total facility capacity now stands at 3.2 GW.
- solar module manufacturing capacity
- 1600 MW
Studds Accessories Production Started
Studds Accessories commenced commercial production at its Manufacturing Facility-V in Faridabad on October 30, 2026, after receiving Consent to Operate. No capacity or monetary value was disclosed.
NTPC Green Energy Production Started
NTPC Green Energy's subsidiary declared commercial operations for 95.6 MW of its Kalasar Solar Energy Project effective October 30, 2026.
- solar capacity
- 95.6 MW
NTPC Production Started
NTPC's subsidiary NVVN declared its first 250 MW / 500 MWh BESS project commercial from 27 October 2026, with power scheduling starting 28 October. This is a commercial operation start for a new energy storage asset.
- battery energy storage capacity
- 250.0 MW
DCM Shriram Production Started
DCM Shriram announced full commissioning of its ~68 MW wind-solar hybrid renewable power project. The project is held through SPV JSW Renew Energy Thirty Two Limited.
- wind-solar hybrid renewable power capacity
- 68.0 MW